UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-10, Vol.375 (14), p.1319-1331

2016

Volltextzugriff (PDF)

Is homecare management associated with longer latency in preterm premature rupture of membranes?

Archives of gynecology and obstetrics, 2020, Vol.301 (1), p.61-67

2020

Volltextzugriff (PDF)

Saved by its back : An amazing story of uterine rupture

European journal of obstetrics & gynecology and reproductive biology, 2017-08, Vol.215, p.257-258

2017

Volltextzugriff (PDF)

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-10, Vol.375 (14), p.1319-1331

2016

Volltextzugriff (PDF)

On the importance of representative datasets in ECG-based artificial intelligence

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Detecting a broader spectrum of cardiac pathologies in electrocardiogram data by applying a deep neural network designed to detect a specific cardiac disease

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

A data-pipeline processing electrocardiogram recordings for use in artificial intelligence algorithms

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Predicting mortality in cardiovascular patients using electrocardiogram data and artificial intelligence

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Phase III results for the novel neurokinin-1 (NK-1) receptor antagonist, casopitant: 3-Day IV/oral dosing regimen for chemotherapy-induced nausea and vomiting (CINV) in patients (Pts) receiving highly emetogenic chemotherapy (HEC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20585-20585

2008

Volltextzugriff (PDF)

Phase III results of a novel oral neurokinin-1 (NK-1) receptor antagonist, casopitant: Single oral and 3-day oral dosing regimens for chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving moderately emetogenic chemotherapy (MEC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9540-9540

2008

Volltextzugriff (PDF)

Phase III results for the novel neurokinin-1 (NK-1) receptor antagonist, casopitant: Single oral dosing regimen for chemotherapy-induced nausea and vomiting (CINV) in patients (Pts) receiving highly emetogenic chemotherapy (HEC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.9549-9549

2008

Volltextzugriff (PDF)

Saved by its back : An amazing story of uterine rupture

European journal of obstetrics, gynecology, and reproductive biology, 2017, Vol.215, p.257-258

2017

Volltextzugriff (PDF)

Position control of a spherical joint using feedback linearization for SMA wire actuators

2010 IEEE/ASME International Conference on Advanced Intelligent Mechatronics, 2010, p.1350-1355

2010

Volltextzugriff (PDF)

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

The Lancet (British edition), 2012-07, Vol.380 (9839), p.358-365

2012

Volltextzugriff (PDF)

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Blood, 2016-10, Vol.128 (14), p.1821-1828

2016

Volltextzugriff (PDF)

Frequency and biodiversity of 2,4-diacetylphloroglucinol-producing bacteria isolated from the maize rhizosphere at different stages of plant growth

Applied and Environmental Microbiology, 2000-03, Vol.66 (3), p.948-955

2000

Volltextzugriff (PDF)

Angeborene Stoffwechselkrankheiten: eine Versorgung im Netzwerk

Bulletin des Médecins Suisses, 2018-10

Guckert, Christine

2018

Volltextzugriff (PDF)

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial

The lancet oncology, 2009-06, Vol.10 (6), p.549-558

2009

Volltextzugriff (PDF)

Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5363-5369

2009

Volltextzugriff (PDF)

Multi-Agent Modelling Notation (MAMN): A Multi-layered Graphical Modelling Notation for Agent-Based Simulations

PRIMA 2022: Principles and Practice of Multi-Agent Systems, p.640-649

Volltextzugriff (PDF)

Electronic Structure of the Reduced Blue Copper Active Site: Contributions to Reduction Potentials and Geometry

Journal of the American Chemical Society, 1995-03, Vol.117 (10), p.2817-2844

1995

Volltextzugriff (PDF)

Characterization of the apoptotic response of human leukemia cells to organosulfur compounds

BMC cancer, 2010-07, Vol.10 (1), p.351-351, Article 351

2010

Volltextzugriff (PDF)

AGADE Traffic 2.0 - A Knowledge-Based Approach for Multi-agent Traffic Simulations

Advances in Practical Applications of Agents, Multi-Agent Systems, and Trustworthiness. The PAAMS Collection, p.417-420

Volltextzugriff (PDF)

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Updated Results of a Phase 1/2 Study (GEN503)

Blood, 2015-12, Vol.126 (23), p.507-507

2015

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Is homecare management associated with longer latency in preterm premature rupture of membranes?

Saved by its back : An amazing story of uterine rupture

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

On the importance of representative datasets in ECG-based artificial intelligence

Detecting a broader spectrum of cardiac pathologies in electrocardiogram data by applying a deep neural network designed to detect a specific cardiac disease

A data-pipeline processing electrocardiogram recordings for use in artificial intelligence algorithms

Predicting mortality in cardiovascular patients using electrocardiogram data and artificial intelligence

Phase III results for the novel neurokinin-1 (NK-1) receptor antagonist, casopitant: 3-Day IV/oral dosing regimen for chemotherapy-induced nausea and vomiting (CINV) in patients (Pts) receiving highly emetogenic chemotherapy (HEC)

Phase III results of a novel oral neurokinin-1 (NK-1) receptor antagonist, casopitant: Single oral and 3-day oral dosing regimens for chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving moderately emetogenic chemotherapy (MEC)

Phase III results for the novel neurokinin-1 (NK-1) receptor antagonist, casopitant: Single oral dosing regimen for chemotherapy-induced nausea and vomiting (CINV) in patients (Pts) receiving highly emetogenic chemotherapy (HEC)

Saved by its back : An amazing story of uterine rupture

Position control of a spherical joint using feedback linearization for SMA wire actuators

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Frequency and biodiversity of 2,4-diacetylphloroglucinol-producing bacteria isolated from the maize rhizosphere at different stages of plant growth

Angeborene Stoffwechselkrankheiten: eine Versorgung im Netzwerk

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial

Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

Multi-Agent Modelling Notation (MAMN): A Multi-layered Graphical Modelling Notation for Agent-Based Simulations

Electronic Structure of the Reduced Blue Copper Active Site: Contributions to Reduction Potentials and Geometry

Characterization of the apoptotic response of human leukemia cells to organosulfur compounds

AGADE Traffic 2.0 - A Knowledge-Based Approach for Multi-agent Traffic Simulations

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Updated Results of a Phase 1/2 Study (GEN503)

Suchergebnisse filtern